The combination of chemotherapy and immune checkpoint inhibitors in recurrent extensive-stage small cell lung cancer: a case report
Abstract Small cell lung cancer (SCLC) accounts for approximately 15% of all lung cancer cases and is characterized by high malignancy, rapid progression, and poor prognosis. Here, we report a case of a 58-year-old female patient who was initially diagnosed with extensive-stage SCLC (ES-SCLC) with l...
Saved in:
| Main Authors: | Chunxiu Hu, Mingtu Zhang, Min Fang, Yi Liu, Zhengqi Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Cardiothoracic Surgery |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13019-025-03513-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the safety and efficacy of combination immune checkpoint inhibitors and chemotherapy treatment in extensive-stage small cell lung cancer
by: Yalin Xie, et al.
Published: (2025-05-01) -
Efficacy and safety of upfront radiotherapy with immune checkpoint inhibitors for brain metastasis in non-small cell lung cancer
by: Yu Tanaka, et al.
Published: (2025-01-01) -
Immune checkpoint inhibitors in metastatic colorectal cancer therapy (a review)
by: P. P. Sorochan, et al.
Published: (2022-07-01) -
The role of radiotherapy in extensive-stage small cell lung cancer: insights from treatment failure patterns in the era of immunotherapy
by: Ya Zhang, et al.
Published: (2024-12-01) -
Addition of thoracic radiotherapy to a PD-L1 inhibitor plus chemotherapy regimen delays brain metastasis onset in extensive-stage small cell lung cancer patients without baseline brain metastasis
by: Baiyang Huang, et al.
Published: (2025-03-01)